ATE108634T1 - Erregung der chemotaxe durch chemotaktische peptide. - Google Patents

Erregung der chemotaxe durch chemotaktische peptide.

Info

Publication number
ATE108634T1
ATE108634T1 AT89905999T AT89905999T ATE108634T1 AT E108634 T1 ATE108634 T1 AT E108634T1 AT 89905999 T AT89905999 T AT 89905999T AT 89905999 T AT89905999 T AT 89905999T AT E108634 T1 ATE108634 T1 AT E108634T1
Authority
AT
Austria
Prior art keywords
peptide
forming residue
chemotactic
biocompatible
integer
Prior art date
Application number
AT89905999T
Other languages
English (en)
Inventor
Dan W Urry
Marianna Long
Original Assignee
Uab Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab Research Foundation filed Critical Uab Research Foundation
Application granted granted Critical
Publication of ATE108634T1 publication Critical patent/ATE108634T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
AT89905999T 1988-04-21 1989-04-05 Erregung der chemotaxe durch chemotaktische peptide. ATE108634T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/184,147 US4976734A (en) 1985-10-31 1988-04-21 Stimulation of chemotaxis by chemotactic peptides

Publications (1)

Publication Number Publication Date
ATE108634T1 true ATE108634T1 (de) 1994-08-15

Family

ID=22675755

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89905999T ATE108634T1 (de) 1988-04-21 1989-04-05 Erregung der chemotaxe durch chemotaktische peptide.

Country Status (6)

Country Link
US (1) US4976734A (de)
EP (1) EP0366777B1 (de)
JP (1) JPH03501574A (de)
AT (1) ATE108634T1 (de)
DE (1) DE68916900T2 (de)
WO (1) WO1989010098A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05507276A (ja) * 1990-05-03 1993-10-21 ニュー・イングランド・ディーコネス・ホスピタル・コーポレイション 動脈造影用合成ペプチド類
WO1993011784A1 (en) * 1991-12-13 1993-06-24 Duke University Methods for inhibition or stimulation of the inflammatory response
DE69527141T2 (de) 1994-04-29 2002-11-07 Scimed Life Systems Inc Stent mit kollagen
US6372228B1 (en) 1994-11-15 2002-04-16 Kenton W. Gregory Method of producing elastin, elastin-based biomaterials and tropoelastin materials
US6087552A (en) * 1994-11-15 2000-07-11 Sisters Of Providence Of Oregon Method of producing fused biomaterials and tissue
US5989244A (en) * 1994-11-15 1999-11-23 Gregory; Kenton W. Method of use of a sheet of elastin or elastin-based material
US7001328B1 (en) 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
US6004782A (en) * 1995-04-14 1999-12-21 Bioelastics Research Ltd. Hyperexpression of bioelastic polypeptides
US5854387A (en) * 1995-04-14 1998-12-29 Bioelastics Research, Ltd. Simple method for the purification of a bioelastic polymer
US5972406A (en) * 1995-04-14 1999-10-26 Bioelastics Research Ltd. Bioelastomers suitable as food product additives
EP0920452A1 (de) * 1996-08-22 1999-06-09 Children's Medical Center Corporation Von osteopontin abgeleitete chemotaktische peptide und deren verwendung
GB9714276D0 (en) 1997-07-08 1997-09-10 Univ Dundee Peptides and related compounds
US6113636A (en) * 1997-11-20 2000-09-05 St. Jude Medical, Inc. Medical article with adhered antimicrobial metal
EP1056413A4 (de) * 1998-02-27 2003-08-20 Bioelastics Res Ltd Injizierbare implantate zur vergrösserung und wiederherstellung von gewebe
US6903244B1 (en) 1999-02-26 2005-06-07 University Of Utah Research Foundation Mice which are +/− or −/− for the elastin gene as models for vascular disease
US20050048614A1 (en) * 2000-06-13 2005-03-03 Children's Medical Center Corporation Biosynthetic oncolytic molecules and uses therefor
US7198798B2 (en) * 2001-05-10 2007-04-03 University Of Washington Methods and devices for promoting endothelial morphogenesis
EP1578352A2 (de) * 2002-03-27 2005-09-28 University of Utah Research Foundation Elastin verhindert den verschluss von körpergefässen durch glatte gefässmuskelzellen
JP2008532942A (ja) * 2005-02-25 2008-08-21 ユニバーシティ オブ ユタ リサーチ ファウンデーション 内皮細胞接着または遊走を促進する方法および組成物
US8470967B2 (en) 2010-09-24 2013-06-25 Duke University Phase transition biopolymers and methods of use
US10392611B2 (en) 2013-05-30 2019-08-27 Duke University Polymer conjugates having reduced antigenicity and methods of using the same
US10364451B2 (en) 2013-05-30 2019-07-30 Duke University Polymer conjugates having reduced antigenicity and methods of using the same
GB201400472D0 (en) * 2014-01-13 2014-02-26 Nordic Bioscience As Biochemical Markers for pulmonary and other diseases
WO2016154530A1 (en) 2015-03-26 2016-09-29 Duke University Targeted therapeutic agents comprising multivalent protein-biopolymer fusions
JP6882782B2 (ja) 2015-08-04 2021-06-02 デューク ユニバーシティ 遺伝子コードされた本質的に無秩序な送達用ステルスポリマーおよびその使用方法
US11752213B2 (en) 2015-12-21 2023-09-12 Duke University Surfaces having reduced non-specific binding and antigenicity
US11467156B2 (en) 2016-06-01 2022-10-11 Duke University Nonfouling biosensors
CN109890833A (zh) 2016-09-14 2019-06-14 杜克大学 用于递送亲水性药物的基于三嵌段多肽的纳米粒子
KR20190064600A (ko) 2016-09-23 2019-06-10 듀크 유니버시티 Lcst 거동을 갖는 비구조화된 비-반복적 폴리펩티드
US11648200B2 (en) 2017-01-12 2023-05-16 Duke University Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
WO2018213320A1 (en) 2017-05-15 2018-11-22 Duke University Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
WO2019006374A1 (en) 2017-06-30 2019-01-03 Duke University ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-SENSITIVE BIOPOLYMER NETWORKS
EP3829622A4 (de) 2018-08-02 2022-05-11 Duke University Doppel-agonisten-fusionsproteine
US11512314B2 (en) 2019-07-12 2022-11-29 Duke University Amphiphilic polynucleotides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4589881A (en) * 1982-08-04 1986-05-20 La Jolla Cancer Research Foundation Polypeptide
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
US4605413A (en) * 1983-09-19 1986-08-12 The University Of Alabama At Birmingham Stimulation of chemotaxis by chemotactic peptides
US4693718A (en) * 1985-10-31 1987-09-15 University Of Alabama In Birmingham Stimulation of chemotaxis by chemotactic peptides

Also Published As

Publication number Publication date
DE68916900T2 (de) 1995-01-19
EP0366777A4 (en) 1991-01-16
EP0366777A1 (de) 1990-05-09
DE68916900D1 (de) 1994-08-25
WO1989010098A1 (en) 1989-11-02
US4976734A (en) 1990-12-11
JPH03501574A (ja) 1991-04-11
EP0366777B1 (de) 1994-07-20

Similar Documents

Publication Publication Date Title
DE68916900D1 (de) Erregung der chemotaxe durch chemotaktische peptide.
CA2052375A1 (en) Parathyroid hormone derivatives
ATE442159T1 (de) Parathyroidhormon analoge
SE9100799L (sv) Rekombinant derivat av human faktor viii
HK1071909A1 (en) Gene and polypeptide sequences
DK0479912T3 (da) Fremgangsmåde til hæmning af N-endereglens forløb i levende celler
SG63621A1 (en) Cytotoxic t lymphocyte-inducing lipopeptides and use as vaccines
EP0761684A3 (de) Alanine Substituierungsanaloge von Magaininpeptiden
NO964959L (no) Nye peptider med immunmodulerende virkninger
ATE42308T1 (de) Pharmakologisch aktive peptide.
ATE362769T1 (de) Lineare kationische peptide mit fungizider wirksamkeit
NO963851L (no) Biotinderivater
EP0244169A3 (de) Peptide mit ANF-Wirksamkeit
ATE25984T1 (de) Pharmakologisch aktive peptide.
ATE108455T1 (de) Segmentierte polypeptid-bioelastomere zur modulierung des elastizitaetsmoduls.
GB1532181A (en) Pentapetides and a method of preparing them
AR009805A1 (es) Peptidos que contienen cisteina
CA2083286A1 (en) Recombinant fibrinogenases, preparation and use thereof
RU97117935A (ru) Свойства пептидов, стимулирующих рост
FI834083A (fi) Peptider
ECSP003720A (es) Peptidos modificados y peptidomimeticos para el uso en inmunoterapia

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee